Biology of advanced uveal melanoma and next steps for clinical therapeutics-Reference-Cited by-同舟云学术

Biology of advanced uveal melanoma and next steps for clinical therapeutics

Published:2014-09-01 Issue:2 Volume:28 Page:135-147
ISSN:1755-1471
Container-title:Pigment Cell & Melanoma Research
language:en
Short-container-title:Pigment Cell Melanoma Res.

Author:

Luke Jason J.¹,Triozzi Pierre L.²,McKenna Kyle C.³,Van Meir Erwin G.⁴,Gershenwald Jeffrey E.⁵,Bastian Boris C.⁶,Gutkind J. Silvio⁷,Bowcock Anne M.⁸,Streicher Howard Z.⁹,Patel Poulam M.¹⁰,Sato Takami¹¹,Sossman Jeffery A.¹²,Sznol Mario¹³,Welch Jack⁹,Thurin Magdalena⁹,Selig Sara¹⁴,Flaherty Keith T.¹⁵,Carvajal Richard D.¹⁶

Affiliation:

1. Dana-Farber Cancer Institute; Harvard Medical School; Boston MA USA

2. Wake Forest University Cancer Center; Medical Center Boulevard; Winston-Salem NC USA

3. University of Pittsburgh Cancer Institute; Pittsburgh PA USA

4. School of Medicine; The Winship Cancer Institute of Emory University; Atlanta GA USA

5. University of Texas MD Anderson Cancer Center; Houston TX USA

6. University of California San Francisco Helen Diller Comprehensive Cancer Center; San Francisco CA USA

7. National Institute of Dental and Craniofacial Research; Bethesda MD USA

8. National Heart & Lung Institute; Imperial College; London UK

9. National Cancer Institute; Bethesda MD USA

10. University of Nottingham; Nottingham UK

11. The Kimmel Cancer Center; Thomas Jefferson University; Philadelphia PA USA

12. Vanderbilt-Ingram Cancer Center; Vanderbilt University; Nashville TN USA

13. Yale Cancer Center; Yale University; New Haven CT USA

14. Brigham and Woman's Hospital and the Melanoma Research Foundation; CURE OM; Washington DC USA

15. Massachusetts General Hospital Cancer Center; Harvard Medical School; Boston MA USA

16. Memorial-Sloan Kettering Cancer Center; New York NY USA

Funder

NIH

Samuel Waxman Cancer Research Foundation

Publisher

Wiley

Subject

Dermatology,General Biochemistry, Genetics and Molecular Biology,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/pcmr.12304/fullpdf

Reference118 articles.

1. Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers;Abdel-Rahman;J. Med. Genet.,2011

2. Circulating immune cell and microRNA in patients with uveal melanoma developing metastatic disease;Achberger;Mol. Immunol.,2014

3. Insulin-like growth factor-1 receptor in uveal melanoma: a predictor for metastatic disease and a potential therapeutic target;All-Ericsson;Invest. Ophthalmol. Vis. Sci.,2002

4. Identification of unique MEK-dependent genes in GNAQ mutant uveal melanoma involved in cell growth, tumor cell invasion, and MEK-resistance;Ambrosini;Clin. Cancer Res.,2012

5. Inhibition of mutant GNAQ signaling in uveal melanoma induces AMPK-dependent autophagic cell death;Ambrosini;Mol. Cancer Ther.,2013

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Uveal melanoma: Recent advances in immunotherapy;World Journal of Clinical Oncology;2024-01-24

2. Imipridones inhibit tumor growth and improve survival in an orthotopic liver metastasis mouse model of human uveal melanoma;2024-01-15

3. Recent approaches for the treatment of uveal melanoma: Opportunities and challenges;Critical Reviews in Oncology/Hematology;2024-01

4. ENQUIRE RECONSTRUCTS AND EXPANDS GENE AND MESH CO-OCCURRENCE NETWORKS FROM CONTEXT-SPECIFIC LITERATURE;2023-09-13

5. Efficacy of immune checkpoint inhibition in metastatic uveal melanoma: a systematic review and meta-analysis;Melanoma Research;2023-05-18